Publications by authors named "Mabel Graffigna"

Claim this Profile
I
Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome.
Giselle A Abruzzese, Juan Gamez, Susana H Belli, Oscar A Levalle, Eduardo Mormandi, Mabel N Graffigna

Gynecol Endocrinol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of anthropometric measures for identifying cardiovascular disease risk in adolescents: review and meta-analysis.
Michael Lichtenauer, Sean D Wheatley, Marrissa Martyn-St James, Michael J Duncan, Fernanda Cobayashi, Mabel Graffigna

Minerva Pediatr· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Giselle A Abruzzese, Gloria E Cerrrone, Juan M Gamez, Mabel N Graffigna, Susana Belli

Horm Metab Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten years cardiovascular risk estimation according to Framingham score and non HDL-cholesterol in blood donors.
Mabel Nora Graffigna, Gabriela Berg, Marta Migliano, Pablo Salgado, Jimena Soutelo

Diabetes Metab Syndr· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between β2-adrenoceptor (ADRB2) haplotypes and insulin resistance in PCOS.
Mariana L Tellechea, Damián O Muzzio, Andrea E Iglesias Molli, Susana H Belli, Mabel N Graffigna

Clin Endocrinol (Oxf)· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Triglycerides/HDL-cholesterol ratio: in adolescents without cardiovascular risk factors].
Jimena Soutelo, Mabel Graffigna, Margarita Honfi, Marta Migliano, Marcela Aranguren

Arch Latinoam Nutr· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of -675 4G/5G in the plasminogen activator inhibitor-1 gene and -308G/A tumor necrosis factor-α gene polymorphisms in obese Argentinean patients.
Silvia D Perés Wingeyer, Mabel N Graffigna, Susana H Belli, Jorge Benetucci, Gabriela F de Larrañaga

Genet Test Mol Biomarkers· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiometabolic risk factors as apolipoprotein B, triglyceride/HDL-cholesterol ratio and C-reactive protein, in adolescents with and without obesity: cross-sectional study in middle class suburban children.
Carla Musso, Mabel Graffigna, Jimena Soutelo, Margarita Honfi, Laura Ledesma

Pediatr Diabetes· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome?
Diego Lucero, Valeria Zago, Graciela I López, Mabel Graffigna, Gustavo H López

Clin Chim Acta· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome.
Diego Lucero, Valeria Zago, Graciela I López, Mabel Graffigna, Hugo Fainboim

Clin Chim Acta· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene and obesity in Argentinian Hispanic adults.
Silvia D Perés Wingeyer, Susana H Belli, Mabel N Graffigna, Oscar Levalle, Gabriela F de Larrañaga

Blood Coagul Fibrinolysis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].
Mabel Nora Graffigna, Susana H Belli, Gabriela de Larrañaga, Hugo Fainboim, Claudio Estepo

Acta Gastroenterol Latinoam· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome.
Gabriela de Larrañaga, Silvia Perés Wingeyer, Mabel Graffigna, Susana Belli, Karla Bendezú

Clin Appl Thromb Hemost· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The range of normal values of liver enzymes in the era of metabolic syndrome: the need for a redefinition.
Silvia D Perés Wingeyer, Gabriela F de Larrañaga, Susana H Belli, Mabel N Graffigna, Hugo Fainboim

Eur J Gastroenterol Hepatol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome.
Susana H Belli, Mabel N Graffigna, Adriana Oneto, Patricia Otero, Leon Schurman

Fertil Steril· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis